Assessment of the Molecular International Prognostic Scoring System (IPSS-M) Risk Stratification Model in Hypoplastic Myelodysplastic Syndromes

被引：1
|
作者：
Aguirre, Luis E. [1 ]
Al Ali, Najla [2 ]
Ball, Somedeb [1 ]
Singh, Avani M. [1 ]
Jain, Akriti G. [3 ]
Chan, Onyee [1 ]
Schwabkey, Zaker, I [1 ]
Tinsley-Vance, Sara M. [1 ]
Kuykendall, Andrew [1 ]
Sweet, Kendra [1 ]
Lancet, Jeffrey E. [1 ]
Padron, Eric [1 ]
Sallman, David A. [2 ]
Komrokji, Rami S. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL 33612 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Wesley Chapel, FL USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-171044
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6909 / 6911
页数：3
相关论文
共 50 条
  • [41] Independent Validation of the MD Anderson Cancer Center Risk Model for Myelodysplastic Syndromes (MDS), and Comparison to the International Prognostic Scoring System (IPSS) and the World Health Organization-Based Prognostic Scoring System (WPSS)
    Hugo, Sarah E.
    Bundrick, Sarah C.
    Hanson, Curtis A.
    Steensma, David P.
    BLOOD, 2009, 114 (22) : 1467 - 1468
  • [42] Correlation between flow cytometric patterns of myeloid maturation and international prognostic scoring system (IPSS) for myelodysplastic syndromes (MDS)
    Chianese, R
    Gatti, A
    Mazzone, A
    Valentini, M
    Stioui, S
    Pagani, G
    Brando, B
    CYTOMETRY PART A, 2006, 69A (05) : 448 - 449
  • [43] The Revised International Prognostic Scoring System (IPSS-R) Is Not Predictive Of Survival In Patients With Secondary Myelodysplastic Syndromes (MDS)
    Nazha, Aziz
    Mukherjee, Sudipto
    Tiu, Ramon V.
    Saunthararajah, Yogen
    Keng, Michael K.
    Seastone, David J.
    Hobson, Sean
    Advani, Anjali S.
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    BLOOD, 2013, 122 (21)
  • [44] CC-486 (ORAL AZACITIDINE) IN PATIENTS WITH INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS)-DEFINED HIGHER-RISK MYELODYSPLASTIC SYNDROMES (MDS)
    Garcia-Manero, G.
    Savona, M. R.
    Gore, S. D.
    Cogle, C. R.
    Conkling, P.
    Hetzer, J.
    Dong, Q.
    Ukrainskyj, S. M.
    Skikne, B. S.
    LEUKEMIA RESEARCH, 2015, 39 : S50 - S51
  • [45] Dichotomization of the new revised international prognostic scoring system for a better clinical stratification of patients with myelodysplastic syndromes
    Montoro, Julia
    Pomares, Helena
    Villacampa, Guillermo
    Merchan, Brayan
    Molero, Antonieta
    Alonso, Esther
    Gallur, Laura
    Grau, Javier
    Salamero, Olga
    Roldan, Elisa
    Saumell, Silvia
    Ortega, Margarita
    Sureda, Anna
    Bosch, Francesc
    Arnan, Montserrat
    Valcarcel, David
    LEUKEMIA & LYMPHOMA, 2019, 60 (06) : 1522 - 1527
  • [46] Validation of the Revised International Prognostic Scoring System (R-IPSS) for Patients with Myelodysplastic Syndromes: Therapeutic Implications.
    Mishra, Asmita
    Al Ali, Najla H.
    Corrales-Yepez, Maria
    Padron, Eric
    Zhang, Ling
    Epling-Burnette, Pearlie K.
    Kharfan-Dabaja, Mohamed A.
    Pinilla-Ibarz, Javier
    Little, Bryan J.
    Lancet, Jeffrey E.
    List, Alan F.
    Komrokji, Rami S.
    BLOOD, 2012, 120 (21)
  • [47] Proposal for a new risk model in myelodysplastic syndrome (MDS) that accounts for events not considered in the original International Prognostic Scoring System (IPSS)
    Garcia Manero, G.
    O'Brien, S. M.
    Ravandi, F.
    Cortes, J. E.
    Shan, J.
    Bennett, J. M.
    List, A. F.
    Fenaux, P.
    Sanz, G.
    Issa, J. P.
    Kantarjian, H. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [48] The molecular prognostic scoring system for normal karyotype myelodysplastic syndromes
    Wei Wang
    Yudi Zhang
    Wenli Yang
    Xiaozhen Liu
    Lingxu Jiang
    Wei Lang
    Yingwan Luo
    Xinping Zhou
    Lu Wang
    Li Ye
    Ying Xu
    Liya Ma
    Hongyan Tong
    Journal of Translational Medicine, 23 (1)
  • [49] The Molecular Prognostic Scoring System for Normal Karyotype Myelodysplastic Syndromes
    Wang, Wei
    Zhang, Yudi
    Yang, Wenli
    Han, Yueyuan
    Ge, Zheng
    Tong, Hongyan
    BLOOD, 2023, 142
  • [50] Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification
    Lee, Wan-Hsuan
    Tsai, Ming-Tao
    Tsai, Cheng-Hong
    Tien, Feng-Ming
    Lo, Min-Yen
    Tseng, Mei-Hsuan
    Kuo, Yuan-Yeh
    Liu, Ming-Chih
    Yang, Yi-Tsung
    Chen, Jui-Che
    Tang, Jih-Luh
    Sun, Hsun-, I
    Chuang, Yi-Kuang
    Lin, Liang-In
    Chou, Wen-Chien
    Lin, Chien-Chin
    Hou, Hsin-An
    Tien, Hwei-Fang
    BLOOD CANCER JOURNAL, 2023, 13 (01)
12345